[Restrictive cardiomyopathy caused by cardiac amyloidosis in multiple myeloma].
Geller
J C
JC
Medizinische Universitäts Poliklinik Bonn.
Barkow
U H
UH
Becher
H
H
Zhou
H
H
Vetter
H
H
Glänzer
K
K
D000368:Aged; D000686:Amyloidosis / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000473:pathology; D001706:Biopsy; D002216:Captopril / Q000008:administration & dosage; D002313:Cardiomyopathy, Restrictive / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000473:pathology; D003937:Diagnosis, Differential; D004074:Digitoxin / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D004452:Echocardiography; D015150:Echocardiography, Doppler; D005260:Female; D005665:Furosemide / Q000008:administration & dosage; D006333:Heart Failure / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology; D006439:Hemodynamics / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D007413:Intestinal Mucosa / Q000473:pathology; D009206:Myocardium / Q000473:pathology; D012007:Rectum / Q000473:pathology
D005665:Furosemide; D002216:Captopril; D004074:Digitoxin
Restriktive Kardiomyopathie aufgrund einer kardialen Amyloidose bei multiplem Myelom.